Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation.

Barilà G, Teramo A, Calabretto G, Ercolin C, Boscaro E, Trimarco V, Carraro S, Leoncin M, Vicenzetto C, Cabrelle A, Facco M, Piazza F, Semenzato G, Zambello R.

Blood Cancer J. 2018 Jun 5;8(6):51. doi: 10.1038/s41408-018-0088-1. No abstract available.

2.

STAT3 mutation impacts biological and clinical features of T-LGL leukemia.

Teramo A, Barilà G, Calabretto G, Ercolin C, Lamy T, Moignet A, Roussel M, Pastoret C, Leoncin M, Gattazzo C, Cabrelle A, Boscaro E, Teolato S, Pagnin E, Berno T, De March E, Facco M, Piazza F, Trentin L, Semenzato G, Zambello R.

Oncotarget. 2017 Jun 27;8(37):61876-61889. doi: 10.18632/oncotarget.18711. eCollection 2017 Sep 22.

3.

Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways.

Manni S, Carrino M, Manzoni M, Gianesin K, Nunes SC, Costacurta M, Tubi LQ, Macaccaro P, Taiana E, Cabrelle A, Barilà G, Martines A, Zambello R, Bonaldi L, Trentin L, Neri A, Semenzato G, Piazza F.

Oncotarget. 2017 Feb 28;8(9):14604-14619. doi: 10.18632/oncotarget.14654.

4.

TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis.

Facco M, Cabrelle A, Calabrese F, Teramo A, Cinetto F, Carraro S, Martini V, Calzetti F, Tamassia N, Cassatella MA, Semenzato G, Agostini C.

Clin Mol Allergy. 2015 Aug 3;13(1):16. doi: 10.1186/s12948-015-0022-z. eCollection 2015.

5.

Bone marrow stromal cell-fueled multiple myeloma growth and osteoclastogenesis are sustained by protein kinase CK2.

Manni S, Toscani D, Mandato E, Brancalion A, Quotti Tubi L, Macaccaro P, Cabrelle A, Adami F, Zambello R, Gurrieri C, Semenzato G, Giuliani N, Piazza F.

Leukemia. 2014 Oct;28(10):2094-7. doi: 10.1038/leu.2014.178. Epub 2014 Jun 4. No abstract available.

PMID:
24897506
6.

Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole.

Frezzato F, Trimarco V, Martini V, Gattazzo C, Ave E, Visentin A, Cabrelle A, Olivieri V, Zambello R, Facco M, Zonta F, Cristiani A, Brunati AM, Moro S, Semenzato G, Trentin L.

Br J Haematol. 2014 Jun;165(5):659-72. doi: 10.1111/bjh.12815. Epub 2014 Mar 7.

PMID:
24606526
7.

JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis.

Fiocco U, Accordi B, Martini V, Oliviero F, Facco M, Cabrelle A, Piva L, Molena B, Caso F, Costa L, Scanu A, Pagnin E, Atteno M, Scarpa R, Basso G, Semenzato G, Punzi L, Doria A, Dayer JM.

Immunol Res. 2014 Jan;58(1):61-9. doi: 10.1007/s12026-013-8481-0.

PMID:
24385089
8.

Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells.

Manni S, Brancalion A, Mandato E, Tubi LQ, Colpo A, Pizzi M, Cappellesso R, Zaffino F, Di Maggio SA, Cabrelle A, Marino F, Zambello R, Trentin L, Adami F, Gurrieri C, Semenzato G, Piazza F.

PLoS One. 2013 Sep 27;8(9):e75280. doi: 10.1371/journal.pone.0075280. eCollection 2013.

9.

Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia.

Teramo A, Gattazzo C, Passeri F, Lico A, Tasca G, Cabrelle A, Martini V, Frezzato F, Trimarco V, Ave E, Boscaro E, Piazza F, Facco M, Trentin L, Semenzato G, Zambello R.

Blood. 2013 May 9;121(19):3843-54, S1. doi: 10.1182/blood-2012-07-441378. Epub 2013 Mar 20.

PMID:
23515927
10.

Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.

Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, Weinschenk T, Ochando JC, Cabrelle A, Mandruzzato S, Bronte V.

Cell Rep. 2012 Sep 27;2(3):628-39. doi: 10.1016/j.celrep.2012.08.006. Epub 2012 Sep 6.

11.

HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen.

Frezzato F, Gattazzo C, Martini V, Trimarco V, Teramo A, Carraro S, Cabrelle A, Ave E, Facco M, Zambello R, Tibaldi E, Brunati AM, Semenzato G, Trentin L.

PLoS One. 2012;7(6):e39902. doi: 10.1371/journal.pone.0039902. Epub 2012 Jun 29.

12.

Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.

Manni S, Brancalion A, Tubi LQ, Colpo A, Pavan L, Cabrelle A, Ave E, Zaffino F, Di Maira G, Ruzzene M, Adami F, Zambello R, Pitari MR, Tassone P, Pinna LA, Gurrieri C, Semenzato G, Piazza F.

Clin Cancer Res. 2012 Apr 1;18(7):1888-900. doi: 10.1158/1078-0432.CCR-11-1789. Epub 2012 Feb 20.

13.

ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis.

Zulato E, Favaretto F, Veronese C, Campanaro S, Marshall JD, Romano S, Cabrelle A, Collin GB, Zavan B, Belloni AS, Rampazzo E, Naggert JK, Abatangelo G, Sicolo N, Maffei P, Milan G, Vettor R.

PLoS One. 2011 Apr 26;6(4):e19081. doi: 10.1371/journal.pone.0019081.

14.

Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes.

Fadini GP, Albiero M, Menegazzo L, Boscaro E, Vigili de Kreutzenberg S, Agostini C, Cabrelle A, Binotto G, Rattazzi M, Bertacco E, Bertorelle R, Biasini L, Mion M, Plebani M, Ceolotto G, Angelini A, Castellani C, Menegolo M, Grego F, Dimmeler S, Seeger F, Zeiher A, Tiengo A, Avogaro A.

Circ Res. 2011 Apr 29;108(9):1112-21. doi: 10.1161/CIRCRESAHA.110.234088. Epub 2011 Mar 10.

PMID:
21393578
15.

Sarcoidosis is a Th1/Th17 multisystem disorder.

Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, Ave E, Gattazzo C, Fadini GP, Calabrese F, Semenzato G, Agostini C.

Thorax. 2011 Feb;66(2):144-50. doi: 10.1136/thx.2010.140319. Epub 2010 Dec 7.

PMID:
21139119
16.

In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells.

Bollini S, Pozzobon M, Nobles M, Riegler J, Dong X, Piccoli M, Chiavegato A, Price AN, Ghionzoli M, Cheung KK, Cabrelle A, O'Mahoney PR, Cozzi E, Sartore S, Tinker A, Lythgoe MF, De Coppi P.

Stem Cell Rev Rep. 2011 Jun;7(2):364-80. doi: 10.1007/s12015-010-9200-z.

PMID:
21120638
17.

Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death.

Piazza F, Manni S, Tubi LQ, Montini B, Pavan L, Colpo A, Gnoato M, Cabrelle A, Adami F, Zambello R, Trentin L, Gurrieri C, Semenzato G.

BMC Cancer. 2010 Oct 4;10:526. doi: 10.1186/1471-2407-10-526.

18.

Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes.

Gattazzo C, Teramo A, Miorin M, Scquizzato E, Cabrelle A, Balsamo M, Agostini C, Vendrame E, Facco M, Albergoni MP, Trentin L, Vitale M, Semenzato G, Zambello R.

Haematologica. 2010 Oct;95(10):1722-9. doi: 10.3324/haematol.2010.023358. Epub 2010 Apr 21.

19.

Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells.

Fadini GP, Albiero M, Boscaro E, Menegazzo L, Cabrelle A, Piliego T, Federici M, Agostini C, Avogaro A.

Cell Biol Int. 2010 Jul;34(7):709-15. doi: 10.1042/CBI20090473.

PMID:
20233166
20.

Apoptotic effect of cyclosporin a and dexamethasone in malignant cells of patients with B-chronic lymphocytic leukemia.

Cabrelle A, Maschio N, Carraro S, Frezzato F, Binotto G, Gattazzo C, Miorin M, Agostini C, Zambello R, Pandolfi F, Semenzato G, Trentin L.

J Biol Regul Homeost Agents. 2009 Oct-Dec;23(4):239-50.

PMID:
20003763
21.

3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.

Gurrieri C, Piazza F, Gnoato M, Montini B, Biasutto L, Gattazzo C, Brunetta E, Cabrelle A, Cinetto F, Niero R, Facco M, Garbisa S, Calabrese F, Semenzato G, Agostini C.

J Pharmacol Exp Ther. 2010 Mar;332(3):785-94. doi: 10.1124/jpet.109.153049. Epub 2009 Dec 3.

PMID:
19959748
22.

Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.

Salvi M, Xu D, Chen Y, Cabrelle A, Sarno S, Pinna LA.

Biochem Biophys Res Commun. 2009 Sep 25;387(3):606-10. doi: 10.1016/j.bbrc.2009.07.067. Epub 2009 Jul 17.

PMID:
19616514
23.

Serenoa repens extract targets mitochondria and activates the intrinsic apoptotic pathway in human prostate cancer cells.

Baron A, Mancini M, Caldwell E, Cabrelle A, Bernardi P, Pagano F.

BJU Int. 2009 May;103(9):1275-83. doi: 10.1111/j.1464-410X.2008.08266.x. Epub 2009 Jan 14.

24.

CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis.

Martini G, Cabrelle A, Calabrese F, Carraro S, Scquizzato E, Teramo A, Facco M, Zulian F, Agostini C.

Clin Immunol. 2008 Nov;129(2):268-76. doi: 10.1016/j.clim.2008.06.014. Epub 2008 Aug 28.

PMID:
18760678
25.

Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease.

Cabrelle A, Dell'Aica I, Melchiori L, Carraro S, Brunetta E, Niero R, Scquizzato E, D'Intino G, Calzà L, Garbisa S, Agostini C.

J Leukoc Biol. 2008 Jan;83(1):212-9. Epub 2007 Oct 18.

PMID:
17947392
26.

Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity.

Trentin L, Miorin M, Facco M, Baesso I, Carraro S, Cabrelle A, Maschio N, Bortoli M, Binotto G, Piazza F, Adami F, Zambello R, Agostini C, Semenzato G.

Br J Haematol. 2007 Sep;138(5):594-602.

PMID:
17686053
27.

Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis.

Facco M, Baesso I, Miorin M, Bortoli M, Cabrelle A, Boscaro E, Gurrieri C, Trentin L, Zambello R, Calabrese F, Cassatella MA, Semenzato G, Agostini C.

J Leukoc Biol. 2007 Oct;82(4):946-55. Epub 2007 Jul 5.

PMID:
17615381
28.

Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis.

Dell'Aica I, Niero R, Piazza F, Cabrelle A, Sartor L, Colalto C, Brunetta E, Lorusso G, Benelli R, Albini A, Calabrese F, Agostini C, Garbisa S.

J Pharmacol Exp Ther. 2007 May;321(2):492-500. Epub 2007 Feb 8.

PMID:
17289834
29.

The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo.

Polenghi A, Bossi F, Fischetti F, Durigutto P, Cabrelle A, Tamassia N, Cassatella MA, Montecucco C, Tedesco F, de Bernard M.

J Immunol. 2007 Feb 1;178(3):1312-20.

30.

Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats.

Fadini GP, Sartore S, Schiavon M, Albiero M, Baesso I, Cabrelle A, Agostini C, Avogaro A.

Diabetologia. 2006 Dec;49(12):3075-84. Epub 2006 Oct 27.

PMID:
17072586
31.

Multiple myeloma cell survival relies on high activity of protein kinase CK2.

Piazza FA, Ruzzene M, Gurrieri C, Montini B, Bonanni L, Chioetto G, Di Maira G, Barbon F, Cabrelle A, Zambello R, Adami F, Trentin L, Pinna LA, Semenzato G.

Blood. 2006 Sep 1;108(5):1698-707. Epub 2006 May 9.

PMID:
16684960
32.

The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.

Amedei A, Cappon A, Codolo G, Cabrelle A, Polenghi A, Benagiano M, Tasca E, Azzurri A, D'Elios MM, Del Prete G, de Bernard M.

J Clin Invest. 2006 Apr;116(4):1092-101. Epub 2006 Mar 16.

33.

The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative.

Milanesi E, Costantini P, Gambalunga A, Colonna R, Petronilli V, Cabrelle A, Semenzato G, Cesura AM, Pinard E, Bernardi P.

J Biol Chem. 2006 Apr 14;281(15):10066-72. Epub 2006 Feb 14.

34.

Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glands.

Sfriso P, Oliviero F, Calabrese F, Miorin M, Facco M, Contri A, Cabrelle A, Baesso I, Cozzi F, Andretta M, Cassatella MA, Fiocco U, Todesco S, Konttinen YT, Punzi L, Agostini C.

J Immunol. 2006 Feb 15;176(4):2581-9.

35.
36.

Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis.

Agostini C, Cabrelle A, Calabrese F, Bortoli M, Scquizzato E, Carraro S, Miorin M, Beghè B, Trentin L, Zambello R, Facco M, Semenzato G.

Am J Respir Crit Care Med. 2005 Nov 15;172(10):1290-8. Epub 2005 Aug 11.

PMID:
16100013
37.

Modulation of immune response by the acute and chronic exposure to high altitude.

Facco M, Zilli C, Siviero M, Ermolao A, Travain G, Baesso I, Bonamico S, Cabrelle A, Zaccaria M, Agostini C.

Med Sci Sports Exerc. 2005 May;37(5):768-74.

PMID:
15870630
38.

CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients.

Minuzzo S, Indraccolo S, Tosello V, Piovan E, Cabrelle A, Trentin L, Semenzato G, Amadori A.

Leukemia. 2005 Jun;19(6):1099-101. No abstract available.

PMID:
15830006
39.

PDE-5 inhibitor, Vardenafil, increases circulating progenitor cells in humans.

Foresta C, Lana A, Cabrelle A, Ferigo M, Caretta N, Garolla A, Palù G, Ferlin A.

Int J Impot Res. 2005 Jul-Aug;17(4):377-80.

PMID:
15829988
40.

CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis.

Martini G, Zulian F, Calabrese F, Bortoli M, Facco M, Cabrelle A, Valente M, Zacchello F, Agostini C.

Arthritis Res Ther. 2005;7(2):R241-9. Epub 2005 Jan 7.

41.

Circulating endothelial progenitor cells in subjects with erectile dysfunction.

Foresta C, Caretta N, Lana A, Cabrelle A, Palù G, Ferlin A.

Int J Impot Res. 2005 May-Jun;17(3):288-90.

PMID:
15729373
42.

CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis.

Agostini C, Calabrese F, Poletti V, Marcer G, Facco M, Miorin M, Cabrelle A, Baesso I, Zambello R, Trentin L, Semenzato G.

Respir Res. 2005 Feb 22;6:20.

43.

Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.

Contri A, Brunati AM, Trentin L, Cabrelle A, Miorin M, Cesaro L, Pinna LA, Zambello R, Semenzato G, Donella-Deana A.

J Clin Invest. 2005 Feb;115(2):369-78.

44.

Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis in lymphoma generation.

Piovan E, Tosello V, Indraccolo S, Cabrelle A, Baesso I, Trentin L, Zamarchi R, Tamamura H, Fujii N, Semenzato G, Chieco-Bianchi L, Amadori A.

Blood. 2005 Feb 1;105(3):931-9. Epub 2004 Sep 28.

PMID:
15454484
45.

Antioxidant defences and homeostasis of reactive oxygen species in different human mitochondrial DNA-depleted cell lines.

Vergani L, Floreani M, Russell A, Ceccon M, Napoli E, Cabrelle A, Valente L, Bragantini F, Leger B, Dabbeni-Sala F.

Eur J Biochem. 2004 Sep;271(18):3646-56.

46.

The raft marker GM1 identifies functional subsets of granular lymphocytes in patients with CD3+ lymphoproliferative disease of granular lymphocytes.

Zambello R, Cabrelle A, Trentin L, Agostini C, Semenzato G, Viola A.

Leukemia. 2004 Apr;18(4):771-6.

PMID:
15044927
47.

Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas.

Trentin L, Cabrelle A, Facco M, Carollo D, Miorin M, Tosoni A, Pizzo P, Binotto G, Nicolardi L, Zambello R, Adami F, Agostini C, Semenzato G.

Blood. 2004 Jul 15;104(2):502-8. Epub 2004 Mar 4.

PMID:
15001469
48.

Inhibition of ShcA isoforms p46/p52Shc enhances HIV-1 replication in CD4+ T-lymphocytes.

Benetti L, Calistri A, Ulivieri C, Cabrelle A, Baldari CT, Palù G, Parolin C.

J Cell Physiol. 2004 Apr;199(1):40-6.

PMID:
14978733
49.

Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes.

Zambello R, Falco M, Della Chiesa M, Trentin L, Carollo D, Castriconi R, Cannas G, Carlomagno S, Cabrelle A, Lamy T, Agostini C, Moretta A, Semenzato G, Vitale M.

Blood. 2003 Sep 1;102(5):1797-805. Epub 2003 May 15.

PMID:
12750175
50.

Upregulation of CXCR1 by proliferating cells in patients with lymphoproliferative disease of granular lymphocytes.

Zambello R, Trentin L, Facco M, Carollo D, Cabrelle A, Tosoni A, Cannas G, Nicolardi L, Agostini C, Semenzato G.

Br J Haematol. 2003 Mar;120(5):765-73.

PMID:
12614207

Supplemental Content

Loading ...
Support Center